X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CIPLA TTK HEALTHCARE/
CIPLA
 
P/E (TTM) x 18.4 30.4 60.6% View Chart
P/BV x 2.2 3.2 67.2% View Chart
Dividend Yield % 0.8 0.5 146.3%  

Financials

 TTK HEALTHCARE   CIPLA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
CIPLA
Mar-18
TTK HEALTHCARE/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,458663 219.9%   
Low Rs795479 166.0%   
Sales per share (Unadj.) Rs408.7189.0 216.2%  
Earnings per share (Unadj.) Rs12.917.6 73.1%  
Cash flow per share (Unadj.) Rs23.634.0 69.5%  
Dividends per share (Unadj.) Rs5.003.00 166.7%  
Dividend yield (eoy) %0.40.5 84.5%  
Book value per share (Unadj.) Rs164.9176.7 93.3%  
Shares outstanding (eoy) m14.13805.12 1.8%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x2.83.0 91.2%   
Avg P/E ratio x87.632.5 269.9%  
P/CF ratio (eoy) x47.616.8 283.9%  
Price / Book Value ratio x6.83.2 211.5%  
Dividend payout %38.917.1 228.0%   
Avg Mkt Cap Rs m15,916459,724 3.5%   
No. of employees `0002.223.6 9.5%   
Total wages/salary Rs m1,09026,901 4.1%   
Avg. sales/employee Rs Th2,573.86,446.1 39.9%   
Avg. wages/employee Rs Th485.71,139.4 42.6%   
Avg. net profit/employee Rs Th81.0600.0 13.5%   
INCOME DATA
Net Sales Rs m5,776152,193 3.8%  
Other income Rs m763,577 2.1%   
Total revenues Rs m5,851155,769 3.8%   
Gross profit Rs m42628,264 1.5%  
Depreciation Rs m15213,228 1.2%   
Interest Rs m471,142 4.1%   
Profit before tax Rs m30217,470 1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-28 0.0%   
Extraordinary Inc (Exp) Rs m0-775 0.0%   
Tax Rs m1202,501 4.8%   
Profit after tax Rs m18214,166 1.3%  
Gross profit margin %7.418.6 39.7%  
Effective tax rate %39.714.3 277.5%   
Net profit margin %3.19.3 33.8%  
BALANCE SHEET DATA
Current assets Rs m2,556108,141 2.4%   
Current liabilities Rs m1,67538,322 4.4%   
Net working cap to sales %15.345.9 33.2%  
Current ratio x1.52.8 54.1%  
Inventory Days Days3397 34.5%  
Debtors Days Days3574 47.0%  
Net fixed assets Rs m1,103109,411 1.0%   
Share capital Rs m1411,610 8.8%   
"Free" reserves Rs m2,188140,682 1.6%   
Net worth Rs m2,330142,292 1.6%   
Long term debt Rs m736,621 0.0%   
Total assets Rs m4,073228,606 1.8%  
Interest coverage x7.416.3 45.3%   
Debt to equity ratio x00.3 1.1%  
Sales to assets ratio x1.40.7 213.0%   
Return on assets %5.66.7 84.0%  
Return on equity %7.810.0 78.3%  
Return on capital %14.910.0 150.0%  
Exports to sales %3.032.8 9.1%   
Imports to sales %0.60-   
Exports (fob) Rs m17249,883 0.3%   
Imports (cif) Rs m35NA-   
Fx inflow Rs m17251,691 0.3%   
Fx outflow Rs m5521,033 0.3%   
Net fx Rs m11730,658 0.4%   
CASH FLOW
From Operations Rs m25314,628 1.7%  
From Investments Rs m-226-8,540 2.6%  
From Financial Activity Rs m-72-3,855 1.9%  
Net Cashflow Rs m-412,431 -1.7%  

Share Holding

Indian Promoters % 65.4 16.0 408.8%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 3.7 12.2 30.3%  
FIIs % 5.2 23.7 21.9%  
ADR/GDR % 0.0 1.1 -  
Free float % 25.8 26.2 98.5%  
Shareholders   12,723 161,166 7.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  PIRAMAL ENTERPRISES  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

CIPLA Announces Quarterly Results (4QFY19); Net Profit Up 144.0% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, CIPLA has posted a net profit of Rs 4 bn (up 144.0% YoY). Sales on the other hand came in at Rs 44 bn (up 19.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

CIPLA Announces Quarterly Results (3QFY19); Net Profit Up 17.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, CIPLA has posted a net profit of Rs 3 bn (up 17.5% YoY). Sales on the other hand came in at Rs 40 bn (up 2.4% YoY). Read on for a complete analysis of CIPLA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 23, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS